Published June 15, 2024
| Version v1
Journal article
Open
Evidence from comprehensive independent validation studies for smooth pursuit dysfunction as a sensorimotor biomarker for psychosis
Creators
- Meyhoefer, Inga1
- Sprenger, Andreas2
- Derad, David2
- Grotegerd, , Dominik1
- Leenings, Ramona1
- Leehr, Elisabeth J.1
- Breuer, Fabian1
- Surmann, Marian1
- Rolfes, Karen1
- Arolt, Volker1
- Romer, Georg1
- Lappe, Markus1
- Rehder, Johanna1
- Koutsouleris, Nikolaos3
- Borgwardt, Stefan2
- Schultze-Lutter, Frauke4
- Meisenzahl, Eva4
- Kircher, Tilo T. J.5
- Keedy, Sarah S.6
- Bishop, Jeffrey R.7
- Gershon, Elliot S.6
- 1. University of Muenster
- 2. University of Luebeck
- 3. Ludwig-Maximilian University Munich
- 4. Heinrich-Heine University
- 5. Philipps-University Marburg
- 6. University of Chicago
- 7. University of Minnesota
Description
Smooth pursuit eye movements are considered a well-established and quantifiable biomarker of sensorimotor function in psychosis research. Identifying psychotic syndromes on an individual level based on neurobiological markers is limited by heterogeneity and requires comprehensive external validation to avoid overestimation of prediction models. Here, we studied quantifiable sensorimotor measures derived from smooth pursuit eye movements in a large sample of psychosis probands (N = 674) and healthy controls (N = 305) using multivariate pattern analysis. Balanced accuracies of 64% for the prediction of psychosis status are in line with recent results from other large heterogenous psychiatric samples. They are confirmed by external validation in independent large samples including probands with (1) psychosis (N = 727) versus healthy controls (N = 292), (2) psychotic (N = 49) and non-psychotic bipolar disorder (N = 36), and (3) non-psychotic affective disorders (N = 119) and psychosis (N = 51) yielding accuracies of 65%, 66% and 58%, respectively, albeit slightly different psychosis syndromes. Our findings make a significant contribution to the identification of biologically defined profiles of heterogeneous psychosis syndromes on an individual level underlining the impact of sensorimotor dysfunction in psychosis.
Notes
Data availability
The data can be provided by Rebekka Lencer pending scientific review and a completed material transfer agreement. Requests for the data should be submitted to: Rebekka Lencer.Files
Evidence-from-comprehensive-independent-validation-studies.pdf
Files
(1.2 MB)
| Name | Size | Download all |
|---|---|---|
|
Supplementary information md5:d2e19f94266ab5a805aeaa3a4fb20121 |
96.4 kB | Download |
|
Article md5:f50f88ab81e3ed8b1feb3b84ece90731 |
1.1 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1038/s41598-024-64487-6
- Other
- oai:uchicago.tind.io:12689
Funding
- Projekt DEAL
- National Institute of Mental Health
- MH103366
- National Institute of Mental Health
- MH096900
- National Institute of Mental Health
- MH103368
- National Institute of Mental Health
- MH077851
- National Institute of Mental Health
- MH096913
- National Institute of Mental Health
- MH078113
- National Institute of Mental Health
- MH096942
- National Institute of Mental Health
- MH077945
- National Institute of Mental Health
- MH096957
- National Institute of Mental Health
- MH077852
- National Institute of Mental Health
- MH077862
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- KI 588/14-1
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- KI 588/14-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- KR 3822/7-1
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- KR 3822/7-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- NE 2254/1-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- DA 1151/5-1
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- DA 1151/5-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- SCHW 559/14-1
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- SCHW 559/14–2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- WO 1732/4-1
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- WO 1732/4-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- AL 1145/5-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- CU 43/9-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- GA 545/7-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- RI 908/11-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- WI 3439/3-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- NO 246/10-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- DE 1614/3-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- HA 7070/2-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- JA 1890/7-1
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- JA 1890/7-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- MU 1315/8-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- RE 737/20-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- PF 784/1-2
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- KI 588/17-1
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- CU 43/9-1
- EU-FP7-HEALTH
- 602152
- University of Münster
- Innovative Medical Research
- German Research Council (Deutsche Forschungsgemeinschaft, DFG)
- LE 1122/7-1